A cross-national review of novel oncology approvals in the United States and China (2020-2025)
{{output}}
Introduction: The United States and China are among the largest hubs for oncology drug development and commercialization. We conducted a comprehensive characterization of how the 2 largest oncology drug markets are evolving relat... ...
